Specification

खुराक प्रपत्र
Injection

संकेत
Colorectal, lung, kidney & other cancers

पैकेजिंग (मात्रा प्रति बॉक्स)
1 Vial

लाइफ स्पैन
24 months

मेडिसिन की उत्पत्ति
India

पैकेजिंग का प्रकार
Box

ब्रांड का नाम
Cizumab

नमक की संरचना
Bevacizumab

दवा का प्रकार

सामग्रियां
Bevacizumab

भौतिक रूप

फंक्शन

के लिए सुझाया गया
Cancer treatment

खुराक
100 mg/4 ml

खुराक संबंधी दिशा-निर्देश
As directed by physician

के लिए उपयुक्त

क्वांटिटी
1 vial

स्टोरेज निर्देश
Store at 2-8C

Color
Colorless to pale yellow

Vial Volume
4 ml

Strength Type
100mg/4ml

Single Use
Yes

Parenteral Route
Intravenous

Monoclonal Antibody
Yes

Clear Solution
Yes

Prescription Required
Yes

Trade Information

Minimum Order Quantity
10 Vials

आपूर्ति की क्षमता
प्रति दिन

डिलीवरी का समय
दिन

About

Experience the ultimate in anti-cancer treatment with Cizumab 100mg Bevacizumab Injection. Renowned for its outstanding results and reduced side effects, this monoclonal antibody is in high demand among oncologists and patients. With favorable reviews from healthcare professionals, Cizumab's monumentally effective formula is prescribed for various cancers, including colorectal, lung, and kidney malignancies. Delivered as a clear, single-use, colorless to pale yellow solution, Cizumab ensures targeted therapy. Each 4 ml vial (100mg/4ml) is boxed for safety and has a life span of 24 months, making it a reliable choice for cancer care.

Outstanding Special Features and Reliable Usage

Cizumab 100mg Bevacizumab Injection features a premium, single-use vial containing a colorless to pale yellow, clear solution. With its parenteral intravenous administration, the material is meticulously formulated for maximum efficacy in anti-VEGF, anti-cancer applications. This outstanding monoclonal antibody is packaged for convenience and safety, ensuring compliance with medical standards. It represents a superior option for adult patients requiring advanced cancer therapy, and is always administered under the guidance of physicians.

Premium Domestic and International Reach

Cizumab 100mg enjoys strong market value, both in India's robust domestic mar and across premium global export markets. Its credibility as a reliable anti-cancer agent fuels significant demand among healthcare suppliers, exporters, and traders. The brand's favorable export terms and trusted sample policy ensure accessibility for institutions seeking assurance in quality. With a premium presence worldwide, Cizumab is an outstanding addition to advanced oncology medicine portfolios.

FAQ's of 100mg Cizumab Bevacizumab Injection:

Q: How should Cizumab 100mg Bevacizumab Injection be administered?

A: Cizumab 100mg Bevacizumab Injection must be given via intravenous infusion, strictly under the supervision of a qualified healthcare professional.

Q: What are the main indications for using Cizumab Bevacizumab Injection?

A: This injection is primarily recommended for adults with cancers such as colorectal, lung, kidney, and certain other malignancies as prescribed by the physician.

Q: When should Cizumab Injection be used during cancer treatment?

A: Cizumab is typically introduced during the treatment regimen as determined by your oncologist, depending on cancer type and individual patient needs.

Q: Where can I store the Cizumab Bevacizumab Injection vial?

A: To preserve its efficacy, store the Cizumab vial at a temperature between 2C and 8C, away from direct light and out of reach of children.

Q: What makes Cizumab a favorable option for cancer therapy?

A: Cizumab has received favorable reviews for its targeted action against VEGF, contributing to reduced tumor growth and improved patient outcomes with manageable side effects.

Q: What is the process for acquiring Cizumab as an exporter or supplier?

A: Exporters or suppliers can acquire Cizumab by connecting with authorized distributors in India and may request samples as per the brand's sample policy for quality evaluation.

Tell us about your requirement